Chylothorax in the neonate-A stepwise approach algorithm.
approach
chylothorax
lymph
octreotide
pleural effusion
surgery
Journal
Pediatric pulmonology
ISSN: 1099-0496
Titre abrégé: Pediatr Pulmonol
Pays: United States
ID NLM: 8510590
Informations de publication
Date de publication:
10 2021
10 2021
Historique:
revised:
21
07
2021
received:
23
06
2021
accepted:
24
07
2021
pubmed:
30
7
2021
medline:
15
12
2021
entrez:
29
7
2021
Statut:
ppublish
Résumé
Chylothorax in neonates results from leakage of lymph from thoracic lymphatic ducts and is mainly congenital or posttraumatic. The clinical course of the effusion is heterogeneous, and consensus on treatment, timing, and modalities of measures has not yet been established. This review aims to present, along with levels of evidence and recommendation grades, all current therapeutic possibilities for the treatment of chylothorax in neonates. An extensive search of publications between 1970 and 2020 was performed in the PubMed, Cochrane Database of Systematic Reviews, and UpToDate databases. A stepwise approach algorithm was proposed for both congenital and traumatic conditions to guide the clinician in a rational and systematic way for approaching the treatment of neonates with chylothorax. The treatment strategy for neonatal chylothorax generally involves supportive care and includes drainage and procedures to reduce chyle flow. A stepwise approach starting with the least invasive method is advocated. Progression in the invasiveness of treatment options is determined by the response to previous treatments. A practical stepwise approach algorithm is proposed for both, congenital and traumatic chylothoraces.
Sections du résumé
BACKGROUND
Chylothorax in neonates results from leakage of lymph from thoracic lymphatic ducts and is mainly congenital or posttraumatic. The clinical course of the effusion is heterogeneous, and consensus on treatment, timing, and modalities of measures has not yet been established. This review aims to present, along with levels of evidence and recommendation grades, all current therapeutic possibilities for the treatment of chylothorax in neonates.
METHODS
An extensive search of publications between 1970 and 2020 was performed in the PubMed, Cochrane Database of Systematic Reviews, and UpToDate databases. A stepwise approach algorithm was proposed for both congenital and traumatic conditions to guide the clinician in a rational and systematic way for approaching the treatment of neonates with chylothorax.
DISCUSSION AND CONCLUSION
The treatment strategy for neonatal chylothorax generally involves supportive care and includes drainage and procedures to reduce chyle flow. A stepwise approach starting with the least invasive method is advocated. Progression in the invasiveness of treatment options is determined by the response to previous treatments. A practical stepwise approach algorithm is proposed for both, congenital and traumatic chylothoraces.
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
3093-3105Informations de copyright
© 2021 Wiley Periodicals LLC.
Références
Rocha G. Pleural effusions in the neonate. Curr Opin Pulm Med. 2007;13(4):305-311. https://doi.org/10.1097/MCP.0b013e3281214459 PMID: 17534177
Tutor JD. Chylothorax in infants and children. Pediatrics. 2014;133(4):722-733. https://doi.org/10.1542/peds.2013-2072
Van Straaten HL, Gerards LJ, Krediet TG. Chylothorax in the neonatal period. Eur J Pediatr. 1993;152(1):2-5. https://doi.org/10.1007/BF02072505
Bellini C, Ergaz Z, Boccardo F, et al. Dynamics of pleural fluid effusion and chylothorax in the fetus and newborn: role of the lymphatic system. Lymphology. 2013;46(2):75-84.
Krishnamurthy MB, Malhotra A. Congenital chylothorax: current perspectives and trends. Res Rep Neonatol. 2017;7:53-63. https://doi.org/10.2147/RRN.S128703
Attar MA, Donn SM. Congenital chylothorax. Semin Fetal Neonatal Med. 2017;22(4):234-239. https://doi.org/10.1016/j.siny.2017.03.005
Bialkowski A, Poets CF, Franz AR. Erhebungseinheit für seltene pädiatrische Erkrankungen in Deutschland Study Group. Congenital chylothorax: a prospective nationwide epidemiological study in Germany. Arch Dis Child Fetal Neonatal Ed. 2015;100(2):F169-F172. https://doi.org/10.1136/archdischild-2014-307274
Bengtsson, B-OS. Neonatal lymphatic (chylous) disorders. NeoReviews. 2013;14:E600-e612.
Hargus EP, Carson SD, McGrath RL. Chylothorax and chylopericardial tamponade following Blalock-Taussig anastomosis. J Thorac Cardiovasc Surg. 1978;75:642-645.
Cevese PG, Vecchioni R, D'Amico DF, et al. Postoperative chylothorax: six cases in 2500 operations with a survey of the world literature. J Thorac Cardiovasc Surg. 1975;69:966-971.
Barkat A, Benbouchta I, Karboubi L, Ghanimi Z, Kabiri M. A patient with traumatic chylothorax. Int J Gen Med. 2012;5:759-762. https://doi.org/10.2147/IJGM.S26205
Bessone LN, Ferguson TB, Burford TH. Chylothorax. Ann Thorac Surg. 1971;12(5):527-550. https://doi.org/10.1016/s0003-4975(10)65800-6
McCulloch MA, Conaway MR, Haizlip JA, Buck ML, Bovbjerg VE, Hoke TR. Postoperative chylothorax development is associated with increased incidence and risk profile for central venous thromboses. Pediatr Cardiol. 2008;29(3):556-561. https://doi.org/10.1007/s00246-007-9140-9
Bauman ME, Moher C, Bruce AK, Kuhle S, Kaur S, Massicotte MP. Chylothorax in children with congenital heart disease: incidence of thrombosis. Thromb Res. 2013;132(2):e83-e85. https://doi.org/10.1016/j.thromres.2013.06.014
Borasino S, Diaz F, Masri KE, Dabal RJ, Alten JA. Central venous lines are a risk factor for chylothorax in infants after cardiac surgery. World J Pediatr Congenit Heart Surg. 2014;5(4):522-526. https://doi.org/10.1177/2150135114550723
Coultre CL, Oberhänsli I, Mossaz A, Bugmann P, Faidutti B, Belli DC. Postoperative chylothorax in children: differences between vascular and traumatic origin. J Pediatr Surg. 1991;26(5):519-523. https://doi.org/10.1016/0022-3468(91)90696-q
Wasmuth-Pietzuch A, Hansmann M, Bartmann P, Heep A. Congenital chylothorax: lymphopenia and high risk of neonatal infections. Acta Paediatr. 2004;93(2):220-224. https://doi.org/10.1080/08035250310007312
Reiterer F, Grossauer K, Morris N, Uhrig S, Resch B. Congenital pulmonary lymphangiectasis. Paediatr Respir Rev. 2014;15(3):275-280. https://doi.org/10.1016/j.prrv.2014.05.002
Breslin JW, Yang Y, Scallan JP, Sweat RS, Adderley SP, Murfee WL. Lymphatic vessel network structure and physiology. Compr Physiol. 2018;9(1):207-299. https://doi.org/10.1002/cphy.c180015
Rocha G, Fernandes P, Rocha P, Quintas C, Martins T, Proença E. Pleural effusions in the neonate. Acta Paediatr. 2006;95(7):791-798. https://doi.org/10.1080/08035250500477545
Lichtenstein DA. Ultrasound examination of the lungs in the intensive care unit. Pediatr Crit Care Med. 2009;10(6):693-698. https://doi.org/10.1097/PCC.0b013e3181b7f637
Raimondi F, Cattarossi L, Coppeti R. International perspectives: point-of-care chest ultrasound in the neonatal intensive care unit: an Italian perspective. Neo Reviews. 2014;15(1):e2-e6. https://doi.org/10.1542/neo.15-1-e2
De Angelis LC, Bellini T, Witte MH, et al. Congenital chylothorax: Current evidence-based prenatal and post-natal diagnosis and management. Lymphology. 2019;52(3):108-125
Kugelman A, Gonen R, Bader D. Potential role of high-frequency ventilation in the treatment of severe congenital pleural effusion. Pediatr Pulmonol. 2000;29(5):404-448. https://doi.org/10.1002/(sici)1099-0496(200005)29:5%3C404::aid-ppul11%3E3.0.co;2-4
Chan EH, Russell JL, Williams WG, Van Arsdell GS, Coles JG, McCrindle BW. Postoperative chylothorax after cardiothoracic surgery in children. Ann Thorac Surg. 2005;80(5):1864-1870. https://doi.org/10.1016/j.athoracsur.2005.04.048
Maxwell LG, Fraga MV, Malavolta CP. Assessment of pain in the newborn: an update. Clin Perinatol. 2019;46(4):693-707. https://doi.org/10.1016/j.clp.2019.08.005
Kocel SL, Russell J, O'Connor DL. Fat-modified breast milk resolves chylous pleural effusion in infants with postsurgical chylothorax but is associated with slow growth. JPEN J Parenter Enteral Nutr. 2016;40(4):543-551. https://doi.org/10.1177/0148607114566464
Rocha G, Guerra P, Azevedo I, Guimarães H. Chylothorax in the fetus and the neonate-guidelines for treatment. Rev Port Pneumol. 2007;13(3):377-381. https://doi.org/10.1016/s0873-2159(15)30356-1
Lapillonne A, Fidler Mis N, Goulet O, Van den Akker CHP, Wu J, Koletzko B. ESPGHAN/ESPEN/ESPR/CSPEN working group on pediatric parenteral nutrition. ESPGHAN/ESPEN/ESPR/CSPEN guidelines on pediatric parenteral nutrition: Lipids. Clin Nutr. 2018;37(6 Pt B):2324-2336. https://doi.org/10.1016/j.clnu.2018.06.946
Neumann L, Springer T, Nieschke K, Kostelka M, Dahnert I. ChyloBEST: chylothorax in infants and nutritional with low-fat breast milk. Pediatr Cardiol. 2020;41(1):108-113.
DiLauro S, Russell J, McCrindle B, Tomlinson C, Unger S, O‘Connor D. Growth of cardiac infants with post-surgical chylothorax can besupported using modified fat breast milk with proactivenutrient-enrichment and advancement feeding protocols; an open-label trial. Clin Nutr ESPEN. 2020;38:19-27.
Drewniak M, Lyon AW, Fenton TR. Evaluation of fat separation and removal methods to prepare low-fat breast milk for fat-intolerant neonates with chylothorax. Nutr Clin Pract. 2013;28:599-602.
Wang CD, Chu PS, Mellen BG, Shenai JP. Creamatocrit and the Nutrient Composition of Human Milk. J Perinatol. 1999;19(5):343-346.
The National Academies Press. Dietary reference intakes. Washington, D.C.: National Academy of Sciences; 2015.
O'Neill EF, Radmacher PG, Sparks B, Adamkin DH. Creamatocrit analysis of human milk overestimates fat and energy content when compared toa human milk analyser using mid-infrared spectroscopy. J Pediatr Gastroenterol Nutr. 2013;56:569-572.
Ferris AM, Jensen RG. Lipids in human milk: a review. 1: Sampling, determination, and content. J Pediatr Gastroenterol Nutr. 1984;3:108-122.
Holst N, Jenssen TG, Burhol PG. A characterization of immunoreactive somatostatin in human milk. J Pediatr Gastroenterol Nutr. 1990;10:47-52.
Kocel Sl, Russell J, O'Connor DL. Fat-modified breast milk resolves chylous pleural effusion in infants with postsurgical chylothorax but is associated with slow growth. JPEN J Parenter Enteral Nutr. 2016;40:543-551.
De Halleux V, Rigo J. Variability in human milk composition: benefit of individualized fortification in very-low-birth-weight infants. Am J Clin Nutr. 2013;98:529S-535S.
Buettiker V, Hug MI, Burger R, Baenziger O. Somatostatin: a new therapeutic option for the treatment of chylothorax. Intensive Care Med. 2001;27(6):1083-1086. https://doi.org/10.1007/s001340100959
Cannizzaro V, Frey B, Bernet-Buettiker V. The role of somatostatin in the treatment of persistent chylothorax in children. Eur J Cardiothorac Surg. 2006;30(1):49-53. https://doi.org/10.1016/j.ejcts.2006.03.039
Jochum F, Nomayo A, Hentschel R, Leuchter M, Fusch Ch. Somatostatin-therapeutic option for chylothorax in preterm neonates Report on two patients and review of the literature. Georgian Med News. 2011;193:69-76.
Lowell A, Freda PU. From somatostatin to octreotide LAR: evolution of a somatostatin analogue. Curr Med Res Opin. 2009;25(12):2989-2999. https://doi.org/10.1185/03007990903328959
Testoni D, Hornik CP, Neely ML, et al. Best Pharmaceuticals for Children Act-Pediatric Trials Network Administrative Core Committee. Safety of octreotide in hospitalized infants. Early Hum Dev. 2015;91(7):387-392. https://doi.org/10.1016/j.earlhumdev.2015.04.008
Cheung Y, Leung MP, Yip M. Octreotide for treatment of postoperative chylothorax. J Pediatr. 2001;139(1):157-159. https://doi.org/10.1067/mpd.2001.115572
Young S, Dalgleish S, Ecleston A, Akierman A, McMillan D. Severe congenital chylothorax treated with octreotide. J Perinatol. 2004;24:200-202. https://doi.org/10.1038/sj.jp.7211053
Coulter DM. Successful treatment with octreotide of spontaneous chylothorax in a premature infant. J Perinatol. 2004;24:194-195. https://doi.org/10.1038/sj.jp.7211031
Sivasli E, Dogru D, Aslan AT, Yurdakok M, Tekinnalp G. Spontaneous neonatal chylothorax treated with octreotide in Turkey: a case report. J Perinatol. 2004;24:261-262. https://doi.org/10.1038/sj.jp.7211052
Das A, Shah PS. Octreotide for the treatment of chylothorax in neonates. Cochrane Database Syst Rev. 2010;9:CD006388. https://doi.org/10.1002/14651858.CD006388.pub2
Bellini C, Cabano R, De Angelis LC, et al. Octreotide for congenital and acquired chylothorax in newborns: a systematic review. J Paediatr Child Health. 2018;54(8):840-847. https://doi.org/10.1111/jpc.13889
Ohkura Y, Ueno M, Iizuka T, Haruta S, Tanaka T, Udagawa H. New combined medical treatment with etilefrine and octreotide for chylothorax after esophagectomy: a case report and review of the literature. Medicine (Baltimore). 2015;94(49):e2214. https://doi.org/10.1097/MD.0000000000002214
Ohkura Y, Ueno M, Iizuka T, Udagawa H. Effectiveness of etilefrine regimen for chylothorax after esophagectomy with thoracic duct resection. Esophagus. 2018;15(1):33-38. https://doi.org/10.1007/s10388-017-0592-6
Guillem P, Billeret V, Houcke ML, Triboulet JP. Successful management of post-esophagectomy chylothorax/chyloperitoneum by etilefrine. Dis Esophagus. 1999;12(2):155-156. https://doi.org/10.1046/j.1442-2050.1999.00021.x
Muniz G, Hidalgo-Campos J, Valdivia-Tapia MC, Shaikh N, Carreazo NY. Successful management of chylothorax with etilefrine: case report in 2 pediatric patients. Pediatrics. 2018;141(5):e20163309. https://doi.org/10.1542/peds.2016-3309
Karwa R, Woodis CB. Midodrine and octreotide in treatment of cirrhosis-related hemodynamic complications. Ann Pharmacother. 2009;43(4):692-699. https://doi.org/10.1345/aph.1L373
Liou DZ, Warren H, Maher DP, et al. Midodrine: a novel therapeutic for refractory chylothorax. Chest. 2013;144(3):1055-1057. https://doi.org/10.1378/chest.12-3081
Sivakumar P, Ahmed L. Use of an alpha-1 Adrenoreceptor agonist in the management of recurrent refractory idiopathic chylothorax. Chest. 2018;154(1):e1-e4. https://doi.org/10.1016/j.chest.2018.02.005
Roca CM, Verde MG, Gomez PY, Herranz MIM. CP-071 Midodrine in refractory chylothorax after paediatric cardiac surgery. Eur J Hosp Pharm. 2016;23(1094):1099.
Tamaoka S, Osada A, Kin T, Arimitsu T, Hida M. Midodrine, an oral alpha-1 adrenoreceptor agonist, successfully treated refractory congenital chylous pleural effusion and ascites in a neonate. Chest. 2021;159(4):e189-e191. https://doi.org/10.1016/j.chest.2020.10.071
Ozeki M, Fukao T, Kondo N. Propranolol for intractable diffuse lymphangiomatosis. Engl J Med. 2011;364(14):1380-1382. https://doi.org/10.1056/NEJMc1013217
Borcyk K, Kamil A, Hagerty K, Deer M, Tomich P, Berry ALA. Successful management of extremely high-output refractory congenital chylothorax with chemical pleurodesis using 4% povidone-iodine and propranolol: a case report. Clin Case Rep. 2018;276(4):702-708. https://doi.org/10.1002/ccr3.1449
Hangul M, Kose M, Ozcan A, Unal E. Propranolol treatment for chylothorax due to diffuse lymphangiomatosis. Pediatr Blood Cancer. 2019;66(5):e27592. https://doi.org/10.1002/pbc.27592
Liviskie CJ, Brennan CC, McPherson CC, Vesoulis ZA. Propranolol for the treatment of lymphatic malformations in a neonate-a case report and review of literature. J Pediatr Pharmacol Ther. 2020;25(2):155-162. https://doi.org/10.5863/1551-6776-25.2.155
Rotter A, de Oliveira ZNP. Infantile hemangioma: pathogenesis and mechanisms of action of propranolol. J Dtsch Dermatol Ges. 2017;15:1185-1190. https://doi.org/10.1111/ddg.13365
Swetman GL, Berk DR, Vasanawala SS, Feinstein JA, Lane AT, Bruckner AL. Sildenafil for severe lymphatic malformations. N Engl J Med. 2012 26;366(4):384-386. https://doi.org/10.1056/NEJMc1112482
Marsh CS, Marden B, Newsom R. Severe retinopathy of prematurity (ROP) in a premature baby treated with sildenafil acetate (Viagra) for pulmonary hypertension. Br J Ophthalmol. 2004;88(2):306-307. https://doi.org/10.1136/bjo.2003.021956
Samiee-Zafarghandy S, van den Anker JN, Laughon MM, Clark RH, Smith PB, Hornik CP. Pharmaceuticals for Children Act-Pediatric Trials Network Administrative Core Committee. Sildenafil and retinopathy of prematurity risk in very low birth weight infants. J Perinatol. 2016;36(2):137-140. https://doi.org/10.1038/jp.2015.126
Aboudi D, Swaminathan N, Brumberg H, Shi Q, Friedman D, Parvez B, Krishnan U. Sildenafil and retinopathy of prematurity in preterm infants with bronchopulmonary dysplasia. J Pediatr. 2018;199:16-21. https://doi.org/10.1016/j.jpeds.2018.04.005
Hammill AM, Wentzel M, Gupta A, et al. Sirolimus for the treatment of complicated vascular anomalies in children. Pediatr Blood Cancer. 2011;57(6):1018-1024. https://doi.org/10.1002/pbc.23124
Laforgia N, Schettini F, De Mattia D, Martinelli D, Ladisa G, Favia V. Lymphatic malformation in newborns as the first sign of diffuse lymphangiomatosis: successful treatment with sirolimus. Neonatology. 2016;109(1):52-55. https://doi.org/10.1159/000440939
Young TE, Magnum B. Micromedex NeoFax Essentials. New Jersey: Thomson Reuters; 2020.
Gomella TL, Eyal FG, Bany-Mohammed F. Gomella's Neonatology. Management, Procedures, On-Call Problems, Diseases, and Drugs. 8th edition. New York: McGraw Hill Education; 2020.
Kovacikova L, Lakomy M, Cingelova D. Immunologic status in pediatric cardiosurgical patients with chylothorax. Bratisl Lek Listy. 2007;108(1):3-6.
Orange J, Geha R, Bonilla F. Acute chylothorax in children: selective retention of memory T cells and natural killer cells. J Pediatr. 2003;143:243-249.
Hoskote AU, Ramaiah R, Cale C, Hartley J, Brown K. Role of immunoglobulin supplementation for secondary immunodeficiency associated with chyloyhorax after pediatric cardiothoracic surgery. Pediatr Crit Care Med. 2012;13(5):535-541.
McBride M, Drass J, Berkenbosch J, Wilson W, Tobias J. Hypogammaglobulinemia complicating chylothorax after cardiac surgery in two infants. J Cardiothorac Vasc Anesth. 2001;15(3):358-361.
Mohan H, Paes M, Haynes S. Use of intravenous immunoglobulins as an adjunct in the conservative management of chylothorax. Paediatr Anaesth. 1999;9(1):89-92.
Ohlsson A, Lacy J. Intravenous immunoglobulin for suspected or proven infection in neonates. Cochrane Database Syst Rev. 2020;1(1):CD001239.
Bernet-Buettiker V, Waldvogel K, Cannizzaro V, Albisetti M. Antithrombin activity in children with chylothorax. Eur J Cardiothorac Surg. 2006;29(3):406-409.
Okishio E, Arimitsu T, Miwa M, Matsuzaki Y, Hokuto I, Ikeda K. Metabolic acidosis due to continuous drainage of massive chylous pleural effusion in two neonates. Pediatr Int. 2012;54:732-733.
Breaux J, Marks C. Chylothorax causing reversible T-cell depletion. J Trauma. 1988;28(5):705-707.
Siegler R, Pearce M. Metabolic acidosis from loss of thoracic lymph. J Pediatr. 1978;93(3):465-466.
Beghetti M, La Scala G, Belli D, et al. Etiology and management of pediatric chylothorax. J Pediatr. 2000;136(5):653-658. https://doi.org/10.1067/mpd.2000.104287
Büttiker V, Fanconi S, Burger R. Chylothorax in children: guidelines for diagnosis and management. Chest. 1999;116(3):682-687. https://doi.org/10.1378/chest.116.3.682
Schild HH, Strassburg CP, Welz A, Kalff J. Treatment options in patients with chylothorax. Dtsch Arztebl Int. 2013;110(48):819-826. https://doi.org/10.3238/arztebl.2013.0819
Costa KM, Saxena AK. Surgical chylothorax in neonates: management and outcomes. World J Pediatr. 2018;14(2):110-115. https://doi.org/10.1007/s12519-018-0134-x
Kumar TKS, Balduf K, Boston U, Knott-Craig C. Diaphragmatic fenestration for refractory chylothorax after congenital cardiac surgery in infants. J Thorac Cardiovasc Surg. 2017;154(6):2062-2068. https://doi.org/10.1016/j.jtcvs.2017.08.002
Kumar A, Bin Asaf B, Chugh K, Talwar N. Thoracoscopic ligation of thoracic duct for spontaneous chylothorax. Indian Pediatr. 2013;50(8):796-78
Philips III J, Atkinson J Management of chronic pleural effusions in the neonate. Available (Jan 2021) at www.uptodate.com/contents/management-of-chronic-pleural-effusions-in-the-neonate
Long WG, Cai B, Liu Y, Wang WJ. Povidone-iodine chemical pleurodesis in treating spontaneous chylothorax in pediatric patients. Ann Palliat Med. 2020;9(3):1004-1012. https://doi.org/10.21037/apm-20-926
Hmami F, Oulmaati A, Bouchikhi C, Banani A, Bouharrou A. Chylothorax congénital: une réponse rapide et totale à la polyvidone iodée [Congenital chylothorax: rapid and complete response to polyvidone iodine]. Arch Pediatr. 2014;21(9):1002-1005. https://doi.org/10.1016/j.arcped.2014.06.006
Long WG, Cai B, Deng JM, Liu Y, Wang WJ, Luo J. Chemical pleurodesis and somatostatin in treating spontaneous chylothorax in pediatric patients: a retrospective analysis and review of the literature. Transl Pediatr. 2020;9(4):551-560. https://doi.org/10.21037/tp-20-199
Scottoni F, Fusaro F, Conforti A, Morini F, Bagolan P. Pleurodesis with povidone-iodine for refractory chylothorax in newborns: personal experience and literature review. J Pediatr Surg. 2015;50(10):1722-1725. https://doi.org/10.1016/j.jpedsurg.2015.03.069
Murki S, Faheemuddin M, Gaddam P. Congenital chylothorax--successful management with chemical pleurodesis. Indian J Pediatr. 2010;77(3):332-334. https://doi.org/10.1007/s12098-010-0022-4
Brissaud O, Desfrere L, Mohsen R, Fayon M, Demarquez JL. Congenital idiopathic chylothorax in neonates: chemical pleurodesis with povidone-iodine (Betadine). Arch Dis Child Fetal Neonatal Ed. 2003;88(6):F531-F533. https://doi.org/10.1136/fn.88.6.f531
Drovandi L, Cianchi I, Pratesi S, Dani C. Fibrin glue pleurodesis for pneumothorax in extremely preterm infants: a case report and literature review. Ital J Pediatr. 2018;44(1):91. https://doi.org/10.1186/s13052-018-0533-6
Sarkar S, Hussain N, Herson V. Fibrin glue for persistent pneumothorax in neonates. J Perinatol. 2003;23(1):82-84. https://doi.org/10.1038/sj.jp.7210852
Kim JE, Lee C, Park KI, Park MS, Namgung R, Park IK. Successful pleurodesis with OK-432 in preterm infants with persistent pleural effusion. Korean J Pediatr. 2012;55(5):177-180. https://doi.org/10.3345/kjp.2012.55.5.177
Leung VK, Suen SS, Ting YH, Law LW, Lau TK, Leung TY. Intrapleural injection of OK-432 as the primary in-utero treatment for fetal chylothorax. Hong Kong Med J. 2012;18(2):156-159
O'Brien B, Kesby G, Ogle R, Rieger I, Hyett JA. Treatment of primary fetal hydrothorax with OK-432 (Picibanil): outcome in 14 fetuses and a review of the literature. Fetal Diagn Ther. 2015;37(4):259-266. https://doi.org/10.1159/000363651
Hodges M, Crombleholme TM, Meyers M, et al. Massive fetal chylothorax successfully treated with postnatal talc pleurodesis: a case report and review of the literature. J Ped Surg Case Reports. 2016;9:1-4. https://doi.org/10.1016/j.epsc.2016.03.014
Srinivasa RN, Chick JFB, Gemmete JJ, Hage AN, Srinivasa RN. Endolymphatic interventions for the treatment of chylothorax and chylous ascites in neonates: technical and clinical success and complications. Ann Vasc Surg. 2018;50:269-274.
Majdalany BS, Saad WA, Chick JFB, Khaja MS, Cooper KJ, Srinivasa RN. Pediatric lymphangiography, thoracic duct embolization and thoracic duct disruption: a single-institution experience in 11 children with chylothorax. Pediatr Radiol. 2018;48(2):235-240.
Nadolski G, Itkin M. Thoracic duct embolization for the management of chylothoraces. Curr Opin Pulm Med. 2013;19(4):380-386.
Stecker M, Fan C. Lymphangiography for thoracic duct interventions. Tech Vasc Interventional Rad. 2016;19:277-285.
Itkin M. Interventional treatment of pulmonary lymphatic anomalies. Tech Vasc Interventional Rad. 2016;19:299-304.
Cope C. Diagnosis and treatment of postoperative chyle leakage via percutaneous transabdominal catheterization of the cisterna chyli: a preliminary study. J Vasc Interv Radiol. 1998;9:727-734. https://doi.org/10.1016/S1051-0443(98)70382-3
Case Study: Innovative Treatment for Neonatal Chylothorax, published on Sep 15, 2017 in Neonatology Update (https://www.chop.edu/).
Engum SA, Rescorla FJ, West KW, Scherer LR.3rd, Grosfeld JL The use of pleuroperitoneal shunts in the management of persistent chylothorax in infants. J Pediatr Surg. 1999;34(2):286-290. https://doi.org/10.1016/s0022-3468(99)90192-6
Azizkhan RG, Canfield J, Alford BA, Rodgers BM. Pleuroperitoneal shunts in the management of neonatal chylothorax. J Pediatr Surg. 1983;18(6):842-850. https://doi.org/10.1016/s0022-3468(83)80034-7
Wolff AB, Silen ML, Kokoska ER, Rodgers BM. Treatment of refractory chylothorax with externalized pleuroperitoneal shunts in children. Ann Thorac Surg. 1999;68(3):1053-1057. https://doi.org/10.1016/s0003-4975(99)00880-2
Spiwak E, Wiesenauer C, Panigrahi A, Raj A. Use of pleuroperitoneal shunt in chylothorax related to central line associated thrombosis in sickle cell disease. Children (Basel). 2018 5, (1):7https://doi.org/10.3390/children5010007
Rheuban KS, Kron IL, Carpenter MA, Gutgesell HP, Rodgers BM. Pleuroperitoneal shunts for refractory chylothorax after operation for congenital heart disease. Ann Thorac Surg. 1992;53(1):85-87. https://doi.org/10.1016/0003-4975(92)90762-s
Kramer S, Taylor G, Garfinkel D, Simmons M. Lethal chylothoraces due to superior vena caval thrombosis in infants. AJR Am J Roentgenol. 1981;137(3):559-563.
Berkenbosch J, Monteleone P, Tobias J. Chylothorax following apparently spontaneous central venous thrombosis in a patient with septic schock. Pediatr Pulmonol. 2003;35:230-233.
Dhande V, Kattwinkel J, Alford B. Recurrent bilateral pleural effusions secondary to superior vena cava obstruction as a complication of central venous catheterization. Pediatrics. 1983;72(1):109-113.
Hanna J, Truemper E, Burton E. Superior vena cava thrombosis and chylothorax: relationship in pediatric nephrotic syndrome. Pediatr Nephrol. 1997;11(1):20-22.
Le Coultre C, Oberhansli I, Mossaz A, Bugmann P, Faidutti B, Belli D. Postoperative chylothorax in children: differences between vascular and traumatic in origin. J Pediatr Surg. 1991;26(5):519-523.
Kazanci SY, McElhinney DB, Thiagarajan R, et al. Obstruction of the superior vena cava after neonatal extracorporeal membrane oxygenation: association with chylothorax and outcome of transcatheter treatment. Pediatr Crit Care Med. 2013;14(1):37-43.
Siu SL, Yang JY, Hui JP, et al. Chylothorax secondary to catheter related thrombosis successfully treated with heparin. J Paediatr Child Health. 2012;48(3):E105-E107.
McCulloch M, Conaway M, Haizlip J, Buck M, Bovbjerg V, Koke T. Postoperative chylothorax development is associated with increased incidence and risk profile for central venous thrombosis. Pediatr Cardiol. 2008;29:556-561.
Bauman M, Moher C, Bruce A, Kuhle S, Kaur S, Massicotte M. Chylothorax in children with congenital heart disease: incidence of thrombosis. Thromb Res. 2013;132(2):e83-e85.
Nath DS, Savla J, Khemani RG, Nussbaum DP, Greene CL, Wells WJ. Thoracic duct ligation for persistent chylothorax after pediatric cardiothoracic surgery. Ann Thorac Surg. 2009;88(1):246-251. https://doi.org/10.1016/j.athoracsur.2009.03.083
Kumar TK, Subramanian S, Sathanandam S, Alexander J, Ali M, Knott-Craig CJ. Superior vena cava reconstruction for treatment of chylothorax resulting from thrombosis of superior vena cava in young infants. Ann Thorac Surg. 2015;100(4):1432-1436. https://doi.org/10.1016/j.athoracsur.2015.06.021
Weissler JM, Cho EH, Koltz PF, et al. Lymphovenous anastomosis for the treatment of chylothorax in infants: a novel microsurgical approach to a devastating problem. Plast Reconstr Surg. 2018;141(6):1502-1507. https://doi.org/10.1097/PRS.0000000000004424